Adam Liptak The New York Times 09/18/2008 “Drug Label, Maimed Patient and Crucial Test for Justices”
“Federal pre-emption is the fiercest battle in products liability law today,” said Catherine M. Sharkey, a law professor at New York University. “The court clearly recognizes this, as it has agreed to hear so many cases and seems eager to give clarity to what has been, to date, an indisputably muddled area of law.
… Ms. Levine’s case is shaping up to be the most important business case of the term."
The clarification of this “pre-exemption” law is expected to have potential repercussions for all manufacturers of FDA approved products. For instance, drug companies as well as physicians and schools that attempt to force psychotropic drugs on children may be held liable for damages when tragedy results. Other suits for deaths due to ADHD drugs are waiting in the wings for this US Supreme Court decision (in less than 30 days).
What about the children in Switzerland? No ADHD drugs are administered to school children in Switzerland, home of Novartis.
Eat dust Novartis, may the birds of heaven (America's legal profession) feed on your stinking carcas in the very near future.